EP4235179A3 - Nachweis, quantifizierung und/oder isolierung zirkulierender tumorzellen mittels der expression des cd321-markers - Google Patents
Nachweis, quantifizierung und/oder isolierung zirkulierender tumorzellen mittels der expression des cd321-markers Download PDFInfo
- Publication number
- EP4235179A3 EP4235179A3 EP23172591.2A EP23172591A EP4235179A3 EP 4235179 A3 EP4235179 A3 EP 4235179A3 EP 23172591 A EP23172591 A EP 23172591A EP 4235179 A3 EP4235179 A3 EP 4235179A3
- Authority
- EP
- European Patent Office
- Prior art keywords
- detection
- tumor cells
- marker
- circulating tumor
- quantification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000005443 Circulating Neoplastic Cells Diseases 0.000 title abstract 3
- 238000001514 detection method Methods 0.000 title abstract 2
- 239000003550 marker Substances 0.000 title abstract 2
- 238000002955 isolation Methods 0.000 title 1
- 238000011002 quantification Methods 0.000 title 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70589—CD45
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/54—Determining the risk of relapse
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17161411 | 2017-03-16 | ||
PCT/EP2018/056760 WO2018167312A1 (en) | 2017-03-16 | 2018-03-16 | Detection, quantification and/or isolation of circulating tumor cells based on the expression of cd321 marker |
EP18710884.0A EP3596467B1 (de) | 2017-03-16 | 2018-03-16 | Nachweis, quantifizierung und/oder isolierung zirkulierender tumorzellen mittels der expression des cd321-markers |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP18710884.0A Division EP3596467B1 (de) | 2017-03-16 | 2018-03-16 | Nachweis, quantifizierung und/oder isolierung zirkulierender tumorzellen mittels der expression des cd321-markers |
EP18710884.0A Division-Into EP3596467B1 (de) | 2017-03-16 | 2018-03-16 | Nachweis, quantifizierung und/oder isolierung zirkulierender tumorzellen mittels der expression des cd321-markers |
Publications (2)
Publication Number | Publication Date |
---|---|
EP4235179A2 EP4235179A2 (de) | 2023-08-30 |
EP4235179A3 true EP4235179A3 (de) | 2023-11-15 |
Family
ID=58387669
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP23172591.2A Pending EP4235179A3 (de) | 2017-03-16 | 2018-03-16 | Nachweis, quantifizierung und/oder isolierung zirkulierender tumorzellen mittels der expression des cd321-markers |
EP18710884.0A Active EP3596467B1 (de) | 2017-03-16 | 2018-03-16 | Nachweis, quantifizierung und/oder isolierung zirkulierender tumorzellen mittels der expression des cd321-markers |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP18710884.0A Active EP3596467B1 (de) | 2017-03-16 | 2018-03-16 | Nachweis, quantifizierung und/oder isolierung zirkulierender tumorzellen mittels der expression des cd321-markers |
Country Status (8)
Country | Link |
---|---|
US (1) | US20210190787A1 (de) |
EP (2) | EP4235179A3 (de) |
JP (1) | JP7278595B2 (de) |
KR (1) | KR102583603B1 (de) |
AU (1) | AU2018235021B2 (de) |
CA (1) | CA3054915A1 (de) |
IL (1) | IL269315A (de) |
WO (1) | WO2018167312A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102019202788A1 (de) * | 2019-03-01 | 2020-09-03 | Robert Bosch Gmbh | Verfahren zum Zählen von Zelltypen oder Zellmarkern in einer Probe, insbesondere in einer Blutprobe |
JP2020144054A (ja) * | 2019-03-07 | 2020-09-10 | 学校法人昭和大学 | 末梢血循環癌細胞の検出方法及び検出装置 |
KR102654518B1 (ko) * | 2020-05-26 | 2024-04-04 | 가톨릭대학교 산학협력단 | Lsp1 결핍 t 세포 |
CN113009135B (zh) * | 2021-02-19 | 2024-04-02 | 山东省大健康精准医疗产业技术研究院 | 一种检测cd47的管式磁微粒化学发光免疫定量试剂盒及其制备方法与应用 |
WO2023044118A1 (en) * | 2021-09-20 | 2023-03-23 | Droplet Biosciences, Inc. | Methods for disease assessment using drain fluid |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006130737A1 (en) * | 2005-06-02 | 2006-12-07 | Immunivest Corporation | A method for assessing metastatic carcinomas from circulating endothelial cells and disseminated tumor cells |
WO2007056049A2 (en) * | 2005-11-02 | 2007-05-18 | The Regents Of The University Of Michigan | Molecular profiling of cancer |
EP1813945A1 (de) * | 2005-12-30 | 2007-08-01 | Centocor, Inc. | Verfahren zur Bestimmung des Phänotyps von Zellen |
EP2199798A1 (de) * | 2008-12-18 | 2010-06-23 | Universite Libre De Bruxelles | Diagnoseverfahren und Kit zur Zirkulierung von Tumorzellen |
EP2455403A1 (de) * | 2010-11-23 | 2012-05-23 | Pierre Fabre Medicament | Homogene humanisierte Antikörper gegen JAM-A die Proliferation inhibieren |
WO2013148450A1 (en) * | 2012-03-30 | 2013-10-03 | The Board Of Trustees Of The Leland Stanford Junior University | Use of jam-a in diagnosing and treating leukemia |
WO2014120265A1 (en) * | 2013-02-02 | 2014-08-07 | Duke University | Method of isolating circulating tumor cells |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US5270163A (en) | 1990-06-11 | 1993-12-14 | University Research Corporation | Methods for identifying nucleic acid ligands |
US8980568B2 (en) * | 2001-10-11 | 2015-03-17 | Aviva Biosciences Corporation | Methods and compositions for detecting non-hematopoietic cells from a blood sample |
EP1706720A4 (de) | 2003-10-31 | 2007-02-28 | Vitatex Inc | Bluttest-prototypen und verfahren zum nachweis zirkulierender tumor- und endothelzellen |
GB0808413D0 (en) | 2008-05-09 | 2008-06-18 | Univ Nottingham | Stabilisation of blood cell conjugates |
WO2010037134A2 (en) | 2008-09-29 | 2010-04-01 | Stemlifeline, Inc. | Multi-stage stem cell carcinogenesis |
CN111729090A (zh) | 2013-12-20 | 2020-10-02 | 通用医疗公司 | 与循环肿瘤细胞相关的方法和测定法 |
CN107430116B (zh) | 2015-01-21 | 2020-11-03 | 新加坡科技研究局 | 用于基于大小回收稀有细胞的以柱为基础的装置和方法,及其用途 |
-
2018
- 2018-03-16 EP EP23172591.2A patent/EP4235179A3/de active Pending
- 2018-03-16 JP JP2019551363A patent/JP7278595B2/ja active Active
- 2018-03-16 KR KR1020197030162A patent/KR102583603B1/ko active IP Right Grant
- 2018-03-16 CA CA3054915A patent/CA3054915A1/en active Pending
- 2018-03-16 EP EP18710884.0A patent/EP3596467B1/de active Active
- 2018-03-16 AU AU2018235021A patent/AU2018235021B2/en active Active
- 2018-03-16 US US16/494,223 patent/US20210190787A1/en active Pending
- 2018-03-16 WO PCT/EP2018/056760 patent/WO2018167312A1/en unknown
-
2019
- 2019-09-12 IL IL26931519A patent/IL269315A/en unknown
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006130737A1 (en) * | 2005-06-02 | 2006-12-07 | Immunivest Corporation | A method for assessing metastatic carcinomas from circulating endothelial cells and disseminated tumor cells |
WO2007056049A2 (en) * | 2005-11-02 | 2007-05-18 | The Regents Of The University Of Michigan | Molecular profiling of cancer |
EP1813945A1 (de) * | 2005-12-30 | 2007-08-01 | Centocor, Inc. | Verfahren zur Bestimmung des Phänotyps von Zellen |
EP2199798A1 (de) * | 2008-12-18 | 2010-06-23 | Universite Libre De Bruxelles | Diagnoseverfahren und Kit zur Zirkulierung von Tumorzellen |
EP2455403A1 (de) * | 2010-11-23 | 2012-05-23 | Pierre Fabre Medicament | Homogene humanisierte Antikörper gegen JAM-A die Proliferation inhibieren |
WO2013148450A1 (en) * | 2012-03-30 | 2013-10-03 | The Board Of Trustees Of The Leland Stanford Junior University | Use of jam-a in diagnosing and treating leukemia |
WO2014120265A1 (en) * | 2013-02-02 | 2014-08-07 | Duke University | Method of isolating circulating tumor cells |
Non-Patent Citations (4)
Title |
---|
CARLA KANTARA ET AL: "Methods for detecting circulating cancer stem cells (CCSCs) as a novel approach for diagnosis of colon cancer relapse/metastasis", LABORATORY INVESTIGATION, vol. 95, no. 1, 27 October 2014 (2014-10-27), The United States and Canadian Academy of Pathology, Inc., pages 100 - 112, XP055741024, ISSN: 0023-6837, DOI: 10.1038/labinvest.2014.133 * |
ELAINE A. MCSHERRY ET AL: "JAM-A expression positively correlates with poor prognosis in breast cancer patients", INTERNATIONAL JOURNAL OF CANCER, vol. 125, no. 6, 15 September 2009 (2009-09-15), US, pages 1343 - 1351, XP055241503, ISSN: 0020-7136, DOI: 10.1002/ijc.24498 * |
JEROEN F VAN VELZEN ET AL: "Multicolor flow cytometry for evaluation of platelet surface antigens and activation markers", THROMBOSIS RESEARCH, ELSEVIER, AMSTERDAM, NL, vol. 130, no. 1, 21 February 2012 (2012-02-21), pages 92 - 98, XP028518186, ISSN: 0049-3848, [retrieved on 20120229], DOI: 10.1016/J.THROMRES.2012.02.041 * |
JUSTIN D. LATHIA ET AL: "High-Throughput Flow Cytometry Screening Reveals a Role for Junctional Adhesion Molecule A as a Cancer Stem Cell Maintenance Factor", CELL REPORTS, vol. 6, no. 1, 1 January 2014 (2014-01-01), US, pages 117 - 129, XP055469072, ISSN: 2211-1247, DOI: 10.1016/j.celrep.2013.11.043 * |
Also Published As
Publication number | Publication date |
---|---|
EP4235179A2 (de) | 2023-08-30 |
KR20190142330A (ko) | 2019-12-26 |
IL269315A (en) | 2019-11-28 |
KR102583603B1 (ko) | 2023-10-05 |
JP7278595B2 (ja) | 2023-05-22 |
AU2018235021A1 (en) | 2019-09-12 |
EP3596467A1 (de) | 2020-01-22 |
WO2018167312A1 (en) | 2018-09-20 |
EP3596467C0 (de) | 2023-09-27 |
US20210190787A1 (en) | 2021-06-24 |
JP2020512549A (ja) | 2020-04-23 |
EP3596467B1 (de) | 2023-09-27 |
AU2018235021B2 (en) | 2024-07-11 |
CA3054915A1 (en) | 2018-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4235179A3 (de) | Nachweis, quantifizierung und/oder isolierung zirkulierender tumorzellen mittels der expression des cd321-markers | |
EP3881260A4 (de) | Systeme und verfahren zur geldwäschebekämpfungsanalyse | |
EP3446102A4 (de) | Verfahren, systeme und kits für in-pen-tests | |
WO2018109170A3 (en) | Il-11ra antibodies | |
EP3389481A4 (de) | Verfahren, zusammensetzungen, kits und vorrichtungen zur schnellanalyse von biologischen markern | |
EP3513218A4 (de) | Lokalisierung und verfolgung mithilfe von ortung, signalstärke und pseudostreckendaten | |
PH12017500861A1 (en) | Anti-interleukin-33 antibodies and uses thereof | |
EP4335874A3 (de) | Anti-hla-g-antikörper und verwendung davon | |
WO2020096631A3 (en) | Compositions, methods and systems for protein corona analysis and uses thereof | |
AU2016263598A8 (en) | Methods and kits for treating depression | |
WO2018175636A3 (en) | Compositions and methods for immunooncology | |
MX2016000997A (es) | Metodos y composiciones para detectar contaminacion bacteriana. | |
EP3899379A4 (de) | Lageranordnung für nachführvorrichtung und verfahren zur herstellung und verwendung davon | |
BR112017016897A2 (pt) | cepas fúngicas e métodos de uso | |
EP3721209A4 (de) | Verfahren, systeme und kits für in-pen-tests | |
AU2018269892A8 (en) | NMR methods and systems for the rapid detection of Candida species | |
MX2022000893A (es) | Metodo de obtencion de mitocondrias de celulas y mitocondrias obtenidas. | |
MX2017005888A (es) | Dispositivos, sistemas y metodos para la deteccion de analitos. | |
AR119997A1 (es) | Anticuerpos anti-klk7, anticuerpos anti-klk5, anticuerpos multiespecíficos anti-klk5 / klk7 y métodos de uso | |
EP3573757A4 (de) | Systeme und verfahren zur ganzzelligen analyse | |
EP4234552A3 (de) | 3-phosphoglycerat-dehydrogenase-inhibitoren und verwendungen davon | |
BR112019003824A2 (pt) | sistemas e métodos para mitigar a interferência dentro do espectro ativamente usado | |
EP3706068A4 (de) | Landnutzungsbestimmungssystem, landnutzungsbestimmungsverfahren und -programm | |
EP3693742A3 (de) | Verfahren zum nachweis von prostatakrebs | |
EP3187875A4 (de) | Kit zur messung einer zielsubstanz, system zur messung einer zielsubstanz, kit zur immunochromatographischen messung und system zur immunochromatographischen messung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED |
|
AC | Divisional application: reference to earlier application |
Ref document number: 3596467 Country of ref document: EP Kind code of ref document: P |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: G01N 33/574 20060101AFI20231009BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17P | Request for examination filed |
Effective date: 20240513 |
|
RBV | Designated contracting states (corrected) |
Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
17Q | First examination report despatched |
Effective date: 20240604 |